A new trading day began on Monday, with EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) stock price up 13.43% from the previous day of trading, before settling in for the closing price of $11.58. EYPT’s price has ranged from $3.91 to $14.91 over the past 52 weeks.
During the last 5-year period, the sales growth of Healthcare Sector giant was 15.65%. Meanwhile, its annual earnings per share averaged -30.72%. With a float of $73.49 million, this company’s outstanding shares have now reached $82.79 million.
EyePoint Pharmaceuticals Inc (EYPT) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of EyePoint Pharmaceuticals Inc is 11.23%, while institutional ownership is 74.65%. The most recent insider transaction that took place on Nov 11 ’25, was worth 31,602. In this transaction Chief Medical Officer of this company sold 2,722 shares at a rate of $11.61, taking the stock ownership to the 0 shares. Before that another transaction happened on Nov 11 ’25, when Company’s Officer proposed sale 2,722 for $11.35, making the entire transaction worth $30,895.
EyePoint Pharmaceuticals Inc (EYPT) Earnings and Forecasts
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.64 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.67 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -30.72% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -4.04% during the next five years compared to 15.65% growth over the previous five years of trading.
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) Trading Performance Indicators
Here are EyePoint Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 7.11. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 25.68.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.99, a number that is poised to hit -0.75 in the next quarter and is forecasted to reach -2.87 in one year’s time.
Technical Analysis of EyePoint Pharmaceuticals Inc (EYPT)
Looking closely at EyePoint Pharmaceuticals Inc (NASDAQ: EYPT), its last 5-days average volume was 1.13 million, which is a jump from its year-to-date volume of 0.92 million. As of the previous 9 days, the stock’s Stochastic %D was 68.21%.
During the past 100 days, EyePoint Pharmaceuticals Inc’s (EYPT) raw stochastic average was set at 70.19%, which indicates a significant decrease from 94.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.04 in the past 14 days, which was higher than the 0.77 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.75, while its 200-day Moving Average is $9.21. However, in the short run, EyePoint Pharmaceuticals Inc’s stock first resistance to watch stands at $13.77. Second resistance stands at $14.40. The third major resistance level sits at $15.51. If the price goes on to break the first support level at $12.03, it is likely to go to the next support level at $10.92. Should the price break the second support level, the third support level stands at $10.29.
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) Key Stats
With a market capitalization of 1.09 billion, the company has a total of 82,787K Shares Outstanding. Currently, annual sales are 43,270 K while annual income is -130,870 K. The company’s previous quarter sales were 970 K while its latest quarter income was -59,730 K.
